Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer
Saved in:
Published in: | Gynecologic oncology Vol. 154; pp. 50 - 51 |
---|---|
Main Authors: | , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Elsevier Inc
01-06-2019
|
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Author | O'Cearbhaill, R.E. Liu, Y.L. Aghajanian, C.A. Emengo, V.N. Friedman, C.F. Konner, J. Zamarin, D. |
---|---|
Author_xml | – sequence: 1 givenname: Y.L. surname: Liu fullname: Liu, Y.L. organization: Memorial Sloan Kettering Cancer Center, New York, NY, USA – sequence: 2 givenname: V.N. surname: Emengo fullname: Emengo, V.N. organization: Memorial Sloan Kettering Cancer Center, New York, NY, USA – sequence: 3 givenname: C.F. surname: Friedman fullname: Friedman, C.F. organization: Memorial Sloan Kettering Cancer Center, New York, NY, USA – sequence: 4 givenname: J. surname: Konner fullname: Konner, J. organization: Memorial Sloan Kettering Cancer Center, New York, NY, USA – sequence: 5 givenname: R.E. surname: O'Cearbhaill fullname: O'Cearbhaill, R.E. organization: Memorial Sloan Kettering Cancer Center, New York, NY, USA – sequence: 6 givenname: C.A. surname: Aghajanian fullname: Aghajanian, C.A. organization: Memorial Sloan Kettering Cancer Center, New York, NY, USA – sequence: 7 givenname: D. surname: Zamarin fullname: Zamarin, D. organization: Weill Cornell Medical College, New York, NY, USA |
BookMark | eNp9kMtOwzAQRS1UJNrCF7DxDySMnYftBQtU8ZIqIUT3lmtPwFXrFDuJlL8npaxZzWLmXN05CzILbUBCbhnkDFh9t8vHzzG0OQemcihzxvkFmTNQVVbLSs3IHEBBJnklr8gipR0AFMD4nLx_9NuE3z2GjnZfGM3RY6ImOJr6OPjB7KlpOozUHw59aM8nI_WBRrR9jCeuHUz0JlBrgsV4TS4bs0948zeXZPP0uFm9ZOu359fVwzqzSvLM1XW5ZUKYrRQNs7JkTjnJCqwFcsGtsrYsTN0wVCiUZdOmsk4aWYFwCGWxJMU51sY2pYiNPkZ_MHHUDPRJit7pXyn6JEVDqScpE3V_pnBqNniMOlmPU23np3867Vr_L_8DjJFv9w |
ContentType | Journal Article |
Copyright | 2019 |
Copyright_xml | – notice: 2019 |
DBID | AAYXX CITATION |
DOI | 10.1016/j.ygyno.2019.04.122 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1095-6859 |
EndPage | 51 |
ExternalDocumentID | 10_1016_j_ygyno_2019_04_122 S0090825819306201 |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 1B1 1P~ 1RT 1~. 1~5 29I 3O- 4.4 457 4G. 53G 5GY 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIAV AAIKJ AAKOC AALRI AAOAW AAQFI AAQQT AAQXK AAXUO ABBQC ABFNM ABFRF ABJNI ABLVK ABMAC ABMZM ABXDB ABYKQ ACDAQ ACGFO ACGFS ACRLP ADBBV ADEZE ADFGL ADMUD AEBSH AEFWE AEKER AENEX AEVXI AFCTW AFFNX AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AHPSJ AIEXJ AIKHN AITUG AJBFU AJOXV AJRQY AJUYK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CAG COF CS3 DM4 DU5 EBS EFBJH EFLBG EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HED HMK HMO HVGLF HZ~ IH2 IHE J1W K-O KOM L7B LCYCR LG5 M29 M41 MO0 N9A O-L O9- OAUVE OQ. OZT P-8 P-9 P2P PC. PH~ Q38 R2- RIG ROL RPZ SAE SCC SDF SDG SDP SES SEW SPCBC SSH SSZ T5K UDS UHS UV1 WUQ X7M XPP Z5R ZGI ZMT ZU3 ZXP ~G- AAXKI AAYXX AFJKZ AKRWK CITATION |
ID | FETCH-LOGICAL-c982-d664b177ab87f1c841d9d813e67e272c9cc43a6f1e9e79c113e5cd8a8507de043 |
ISSN | 0090-8258 |
IngestDate | Thu Sep 26 17:59:50 EDT 2024 Fri Feb 23 02:21:49 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c982-d664b177ab87f1c841d9d813e67e272c9cc43a6f1e9e79c113e5cd8a8507de043 |
PageCount | 2 |
ParticipantIDs | crossref_primary_10_1016_j_ygyno_2019_04_122 elsevier_sciencedirect_doi_10_1016_j_ygyno_2019_04_122 |
PublicationCentury | 2000 |
PublicationDate | June 2019 2019-06-00 |
PublicationDateYYYYMMDD | 2019-06-01 |
PublicationDate_xml | – month: 06 year: 2019 text: June 2019 |
PublicationDecade | 2010 |
PublicationTitle | Gynecologic oncology |
PublicationYear | 2019 |
Publisher | Elsevier Inc |
Publisher_xml | – name: Elsevier Inc |
SSID | ssj0003012 |
Score | 2.3242347 |
SourceID | crossref elsevier |
SourceType | Aggregation Database Publisher |
StartPage | 50 |
Title | Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer |
URI | https://dx.doi.org/10.1016/j.ygyno.2019.04.122 |
Volume | 154 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fa9swEBZbB2Uvpds61rUdetjbahPZ8tl6LG3SsHWFtWGMvRhHkksKc0raFPzf9_TDP9KMsg32YoyCE6H7cro73_eJkI9RASABdACCJ5iglINgqpgMQKVRgXdM22M6x5fp-Y_sZMiHXU23G_uvlsYxtLVhzv6FtdsvxQG8R5vjFa2O1z-yu_EEtj3akhQXxQ2mwvYNwe0SvcK9kQawx4LPDDHE069qx2qRXqtpfo8JNP7vpUHEoh--ntaVls5dfppXcqUkfzZbWn8enoVtmP5LV1e2Fvs9PG9HR5idK194PQ5H7fiXeXMM2OewX4ww_CfoFyNalsxKEyeGcYau7iTaQ-0cLYZ2AWReDbzxxAnv-VInSOt3ZadKu-bvXenhOqyv6spQOZkwwrXMUZ0fCWlfmnmYaWDMOoDIkP5eROieTCPoz-Si3b_R5TmNeT_rRqvKdgWu_dDv45lejDLZJls-uaBHDhWvyDNdvSabX337xBvyrQMHbcFBERy0AQe14KAr4KCzirbgoB4c1IFjh0xGw8nxOPBnagRSYC6lALgRHCumWVoymXGmhMpYrCHVURpJISWPCyiZFjoVkuEnRj2iyDBtUHrA47dko5pX-h2hqhTplHEJGhIusmKKuyYvQUGsFJQx2yWHzcLkN045JW9aCq9zu465Wcd8wHNcx10CzeLlPvhzQV2Otn7qwff_-uAeedlBeJ9s3C2W-oA8v1XLDxYQD0O1fWk |
link.rule.ids | 315,782,786,27935,27936 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Subsequent+therapies+and+survival+after+immunotherapy+in+recurrent+ovarian+cancer&rft.jtitle=Gynecologic+oncology&rft.au=Liu%2C+Y.L.&rft.au=Emengo%2C+V.N.&rft.au=Friedman%2C+C.F.&rft.au=Konner%2C+J.&rft.date=2019-06-01&rft.pub=Elsevier+Inc&rft.issn=0090-8258&rft.eissn=1095-6859&rft.volume=154&rft.spage=50&rft.epage=51&rft_id=info:doi/10.1016%2Fj.ygyno.2019.04.122&rft.externalDocID=S0090825819306201 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0090-8258&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0090-8258&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0090-8258&client=summon |